stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / CRL / Gross Profit

Charles River Laboratories International, Inc. Gross Profit 2008–2025

Charles River Laboratories International, Inc. (CRL) annual gross profit by fiscal year, computed from SEC filings. Compound growth +2.4%/yr over 17 years.

Fiscal yearGross ProfitGross marginChange (YoY)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017$1.57B84.4%+11.6%
FY 2016$1.40B83.5%+27.8%
FY 2015$1.10B80.6%+6.6%
FY 2014$1.03B79.5%+15.5%
FY 2013$892.78M76.6%+2.4%
FY 2012$871.82M77.2%-0.3%
FY 2011$874.68M76.5%-0.7%
FY 2010$880.45M77.7%-3.9%
FY 2009$915.96M78.2%-12.1%
FY 2008$1.04B80.5%

Source: Charles River Laboratories International, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Charles River Laboratories International, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Charles River Laboratories International, Inc. — frequently asked questions

What is Charles River Laboratories International, Inc.'s gross profit?

Charles River Laboratories International, Inc. (CRL) reported gross profit of $1.57B for fiscal year 2017, per its SEC filings.

How has Charles River Laboratories International, Inc.'s gross profit changed over time?

Between fiscal 2008 and 2025, CRL's gross profit grew at roughly 2.4% per year (compound annual rate), from $1.04B to $1.57B.

Where does this data come from?

Figures are computed from Charles River Laboratories International, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More CRL financial history

Full CRL fundamentals page → · All 1,500+ companies →